Miriam Butler

1.2k total citations
28 papers, 530 citations indexed

About

Miriam Butler is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Miriam Butler has authored 28 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Miriam Butler's work include Acute Lymphoblastic Leukemia research (7 papers), Estrogen and related hormone effects (5 papers) and CRISPR and Genetic Engineering (3 papers). Miriam Butler is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Estrogen and related hormone effects (5 papers) and CRISPR and Genetic Engineering (3 papers). Miriam Butler collaborates with scholars based in Australia, Netherlands and United States. Miriam Butler's co-authors include Frank N. van Leeuwen, Laurens T. van der Meer, Vicki L. Clifton, Nicolette A. Hodyl, Wayne D. Tilley, Theresa E. Hickey, Astrud Tuck, A. Osei-Kumah, Zarqa Saif and Carmela Ricciardelli and has published in prestigious journals such as Blood, Cancer Research and Stroke.

In The Last Decade

Miriam Butler

26 papers receiving 522 citations

Peers

Countries citing papers authored by Miriam Butler

Since Specialization

Citations

This map shows the geographic impact of Miriam Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Butler more than expected).

Fields of papers citing papers by Miriam Butler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Butler. The network helps show where Miriam Butler may publish in the future.

Co-authorship network of co-authors of Miriam Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Butler. A scholar is included among the top collaborators of Miriam Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Butler. Miriam Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<i>IKZF1</i> gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia 2024 ·Haematologica ·(unknown), Miriam Butler, K Grünewald, Dorette S. van Ingen Schenau, (unknown), (unknown), Alwin D. R. Huitema, Judith M. Boer, Beat Bornhäuser, Jean‐Pierre Bourquin, Peter M. Hoogerbrugge, Vincent H. J. van der Velden, Roland P. Kuiper, Laurens T. van der Meer, Frank N. van Leeuwen	1
2	Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy 2023 ·Haematologica ·(unknown), (unknown), Dorette S. van Ingen Schenau, (unknown), (unknown), (unknown), K Grünewald, (unknown), Miriam Butler, Roland P. Kuiper, Laurens T. van der Meer, Frank N. van Leeuwen	1
3	Abstract TP106: Outcomes Following Off-label Glyburide In Large Hemispheric Infarction: A Single-center Experience 2023 ·Stroke ·(unknown), Karan Patel, (unknown), Miriam Butler, Jesse Thon, James E. Siegler	2
4	Functional Recovery in Patients with Acute Stroke and Pre-Existing Disability: A Natural History Study 2022 ·Journal of Stroke and Cerebrovascular Diseases ·(unknown), (unknown), (unknown), Lauren Thau, Miriam Butler, (unknown), Linda Zhang, T. Oma Hester, Jesse Thon, James E. Siegler	2
5	Unique Clinicopathologic Subclassifiers of Cryptogenic Cerebral Emboli 2022 ·Journal of Stroke and Cerebrovascular Diseases ·James E. Siegler, Lauren Thau, T. Oma Hester, (unknown), (unknown), (unknown), Mark Heslin, (unknown), Linda Zhang, Miriam Butler, (unknown), (unknown), (unknown), (unknown), Pratit Patel, Jesse Thon	3
6	Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways 2022 ·Frontiers in Oncology ·Miriam Butler, (unknown), Dorette S. van Ingen Schenau, (unknown), (unknown), René Marke, Jules P.P. Meijerink, Blanca Scheijen, Laurens T. van der Meer, Frank N. van Leeuwen	6
7	Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade 2022 ·Haematologica ·(unknown), Sabine Macho‐Maschler, Dorette S. van Ingen Schenau, Miriam Butler, Caroline Lassnig, (unknown), (unknown), Katrin Meissl, Barbara Maurer, (unknown), Claus Vogl, Anna Koren, Stefan Kubicek, Anna Orlova, Richard Moriggl, Birgit Strobl, Veronika Sexl, Frank N. van Leeuwen, Roland P. Kuiper, Mathias Mueller	2
8	BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway 2021 ·Blood ·Miriam Butler, Dorette S. van Ingen Schenau, Jiangyan Yu, Silvia Jenni, Maria Pamela Dobay, (unknown), (unknown), (unknown), Fieke W. Hoff, Jules P.P. Meijerink, Steven M. Kornblau, Beat Bornhäuser, Jean‐Pierre Bourquin, Roland P. Kuiper, Laurens T. van der Meer, Frank N. van Leeuwen	17
9	Amino Acid Depletion Therapies: Starving Cancer Cells to Death 2021 ·Trends in Endocrinology and Metabolism ·Miriam Butler, Laurens T. van der Meer, Frank N. van Leeuwen	180
10	Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients 2020 ·Histopathology ·Tanja Jankovic‐Karasoulos, Tina Bianco‐Miotto, Miriam Butler, Lisa M. Butler, Catriona M. McNeil, Sandra A. O’Toole, Ewan K.A. Millar, Andrew J. Sakko, (unknown), Stephen N. Birrell, Robert L. Sutherland, Theresa E. Hickey, Wayne D. Tilley, Carmela Ricciardelli	25
11	Glucocorticoid Resistance in IKZF1-Deleted BCP-ALL: It Is PTEN Again 2018 ·Blood ·(unknown), René Marke, Miriam Butler, (unknown), Blanca Scheijen, Frank N. van Leeuwen	0
12	A CRISPR/Cas9 Based Kinome Screen Identifies Bruton Tyrosine Kinase (BTK) As an Important Determinant of Asparaginase Treatment Response in Acute Lymphoblastic Leukemia 2017 ·Blood ·Miriam Butler, (unknown), Jiangyan Yu, Silvia Jenni, Maria Pamela Dobay, Peter M. Hoogerbrugge, Beat Bornhäuser, Jean‐Pierre Bourquin, Roland P. Kuiper, Frank N. van Leeuwen	2
13	Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in Mice 2016 ·Scientific Reports ·Lisa Philp, Tanya K. Day, Miriam Butler, Geraldine Laven‐Law, Shalini Jindal, Theresa E. Hickey, Howard I. Scher, Lisa M. Butler, Wayne D. Tilley	9
14	The human placenta expresses multiple glucocorticoid receptor isoforms that are altered by fetal sex, growth restriction and maternal asthma 2014 ·Placenta ·Zarqa Saif, Nicolette A. Hodyl, (unknown), Astrud Tuck, Miriam Butler, A. Osei-Kumah, Vicki L. Clifton	78
15	SGTA: A New Player in the Molecular Co-Chaperone Game 2013 ·Hormones and Cancer ·Lisa Philp, Miriam Butler, Theresa E. Hickey, Lisa M. Butler, Wayne D. Tilley, Tanya K. Day	30
16	Small glutamine-rich tetratricopeptide repeat–containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome 2013 ·Fertility and Sterility ·Miriam Butler, Xing Yang, Carmela Ricciardelli, Xiaoyan Liang, Robert J. Norman, Wayne D. Tilley, Theresa E. Hickey	5
17	Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression 2013 ·Hormones and Cancer ·Miriam Butler, Carmela Ricciardelli, Wayne D. Tilley, Theresa E. Hickey	22
18	Localisation and characterisation of uncoupling protein-2 (UCP2) in the human preterm placenta 2012 ·Placenta ·Michael J. Stark, Nicolette A. Hodyl, Miriam Butler, Vicki L. Clifton	8
19	A qualitative study in neurological physiotherapy and hope: Beyond physical improvement 2010 ·Physiotherapy Theory and Practice ·Andrew Soundy, Brett Smith, Miriam Butler, Catherine Lowe, Helen Dawes, (unknown)	33
20	Immunohistochemical Level of Unsulfated Chondroitin Disaccharides in the Cancer Stroma Is an Independent Predictor of Prostate Cancer Relapse 2008 ·Cancer Epidemiology Biomarkers & Prevention ·Andrew J. Sakko, Miriam Butler, Sharon Byers, Betty Reinboth, Jürgen Stahl, James G. Kench, Lisa G. Horvath, Robert L. Sutherland, Phillip D. Stricker, Susan M. Henshall, Villis R. Marshall, Wayne D. Tilley, David J. Horsfall, Carmela Ricciardelli	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact